non-Hodgkin lymphoma

Bayer proposes $7.25 billion settlement to resolve thousands of Roundup cancer lawsuits, with payments spread over 21 years.

Biotech firms advance treatment-resistant cancer therapies across multiple platforms, including oncolytic viruses and cellular immunotherapy, with several candidates achieving regulatory milestones and encouraging clinical data.